Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Q2 2018 Earnings Call August 2, 2018 8:00 AM ET
Executives
Kevin C. Mannix - Teva Pharmaceutical Industries Ltd.
Kåre Schultz - Teva Pharmaceutical Industries Ltd.
Michael McClellan - Teva Pharmaceutical Industries Ltd.
Brendan O'Grady - Teva Pharmaceutical Industries Ltd.
Analysts
Liav Abraham - Citigroup Global Markets, Inc. (Broker)
David Maris - Wells Fargo Securities LLC
Jami Rubin - Goldman Sachs & Co. LLC
Christopher Schott - JPMorgan Securities LLC
Aharon Gal - Sanford C. Bernstein & Co. LLC
Gregg Gilbert - Deutsche Bank Securities, Inc.
Umer Raffat - Evercore Group LLC
Elliot Wilbur - Raymond James & Associates, Inc.
Irina R. Koffler - Mizuho Securities USA LLC
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Teva Pharmaceutical second quarter 2018 financial results call. At this time, all participants are in a listen-only mode. There will be a presentation, followed by a question-and-answer session. I must advise you the conference is being recorded today, Thursday, August 2, 2018.
I would now like to turn the conference over to your first speaker today, Kevin Mannix, Senior Vice President, Head of Investor Relations. Please go ahead.
Kevin C. Mannix - Teva Pharmaceutical Industries Ltd.
Thank you, Steve, and thank you, everyone, for joining us today to discuss Teva's second quarter 2018 financial results. Earlier this morning we issued our press release detailing our results for the quarter. A copy of this release as well as a copy of the slides being presented on the call can be found on our website at www.tevapharm.com, as well as on our Teva Investor Relations app.
Our discussion today includes certain non-GAAP measures as defined by the SEC. Management uses both GAAP financial measures and the disclosed non-GAAP financial measures internally to evaluate and manage the company's operations to better understand its business. Further, management believes the inclusion of non-GAAP financial measures provides meaningful supplementary information to and facilitates analysis by investors in evaluating the company's financial performance, results of operations, and trends. Reconciliation of GAAP to non-GAAP measures are available in our earnings release and in today's presentation.
Today, Kåre Schultz, our Chief Executive Officer, will open the call with some remarks on our annual results, recent events, and outlook for 2018. Mike McClellan, our Chief Financial Officer, will review the second quarter financial results in more detail and discuss additional assumptions around our updated 2018 outlook. Also joining us on the call today Q&A is Brendan O'Grady, Teva's Head of North American Commercial.
And with that, I'll now turn the call over to Kåre. Kåre, please.

